The Brazilian Health Regulatory Agency received a temporary authorization request for the Chinese immunizer Sinopharm. It has not undergone clinical trials in Brazil but has been tested in countries like the United Arab Emirates, Egypt, Argentina, and Peru.
LATEST NEWS
- An Eid al-Adha in Morocco
- AD Ports acquires Brazilian logistics operator CLI
- Former Arab Chamber President Walid Yazigi dies
- Tunisia boosts olive oil export revenues
- IMF sees Brazil resilient amid global uncertainty
- Mauritania pursues reforms to boost growth
- Brazil’s GDP grows 1.1% in the first quarter
- Brazil imports more from Jordan
